Identification of Polyomaviruses in Skin Cancers.


Journal

Intervirology
ISSN: 1423-0100
Titre abrégé: Intervirology
Pays: Switzerland
ID NLM: 0364265

Informations de publication

Date de publication:
2021
Historique:
received: 18 08 2020
accepted: 22 11 2020
pubmed: 17 2 2021
medline: 26 10 2021
entrez: 16 2 2021
Statut: ppublish

Résumé

Polyomaviruses (PyVs) were initially described in animals. They have also been detected in humans with some evidence that could play a role in skin carcinogenesis. This study aimed to verify the presence of PyVs in different skin tumour samples and to make clinical correlations with patients' epidemiological data from Clinics Hospital of Medical School of University of São Paulo, Brazil. This is a cross-sectional study. A random selection was performed of 120 patients with histopathological exams of different cutaneous neoplasms equally divided into 6 groups and 20 patients with normal skin. The available skin specimens were analysed with 2 different techniques of PCR (conventional and real time) for detection of PyV DNA. Concomitantly, retrospective analysis of the respective medical records for the collection of epidemiological data was done. Analyses suitable for categorical data were used to compare the proportion of patients in each group. PyV DNA was found in 25.69% of the samples: 15% in basal cell carcinoma group, 15% in squamous cell carcinoma, 28.57% in melanoma, 15% in dermatofibrosarcoma protuberans, 13.33% in Kaposi sarcoma, 65% in Merkel cell carcinoma (MCC), and none in normal skin. Merkel cell PyV detection was statistically significant in MCC patients (p value <0.01), but no correlations were found between PyVs and others skin tumours. This study demonstrated the presence of PyVs in different skin tumours; however, no association of any PyVs found in any skin tumour with epidemiological data could be shown. Further studies are still needed to elucidate the mechanisms of PyVs in skin carcinogenesis.

Sections du résumé

BACKGROUND BACKGROUND
Polyomaviruses (PyVs) were initially described in animals. They have also been detected in humans with some evidence that could play a role in skin carcinogenesis.
OBJECTIVES OBJECTIVE
This study aimed to verify the presence of PyVs in different skin tumour samples and to make clinical correlations with patients' epidemiological data from Clinics Hospital of Medical School of University of São Paulo, Brazil.
METHODS METHODS
This is a cross-sectional study. A random selection was performed of 120 patients with histopathological exams of different cutaneous neoplasms equally divided into 6 groups and 20 patients with normal skin. The available skin specimens were analysed with 2 different techniques of PCR (conventional and real time) for detection of PyV DNA. Concomitantly, retrospective analysis of the respective medical records for the collection of epidemiological data was done. Analyses suitable for categorical data were used to compare the proportion of patients in each group.
RESULTS RESULTS
PyV DNA was found in 25.69% of the samples: 15% in basal cell carcinoma group, 15% in squamous cell carcinoma, 28.57% in melanoma, 15% in dermatofibrosarcoma protuberans, 13.33% in Kaposi sarcoma, 65% in Merkel cell carcinoma (MCC), and none in normal skin. Merkel cell PyV detection was statistically significant in MCC patients (p value <0.01), but no correlations were found between PyVs and others skin tumours.
CONCLUSION CONCLUSIONS
This study demonstrated the presence of PyVs in different skin tumours; however, no association of any PyVs found in any skin tumour with epidemiological data could be shown. Further studies are still needed to elucidate the mechanisms of PyVs in skin carcinogenesis.

Identifiants

pubmed: 33592613
pii: 000513544
doi: 10.1159/000513544
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119-125

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Pedro V A Costa (PVA)

Department of Dermatology, Clinics Hospital of the Medical School of the University of São Paulo, São Paulo, Brazil.

Patricia S Ishiy (PS)

Department of Dermatology, Clinics Hospital of the Medical School of the University of São Paulo, São Paulo, Brazil.

Paulo R P Urbano (PRP)

Virology Research Laboratory (LIMHC 52), Clinics Hospital of the Medical School of the University of São Paulo, São Paulo, Brazil.

Camila M Romano (CM)

Virology Research Laboratory (LIMHC 52), Clinics Hospital of the Medical School of the University of São Paulo, São Paulo, Brazil.

Stephen K Tyring (SK)

Department of Dermatology, University of Texas Health Science Center, Houston, Texas, USA.

Walmar R P Oliveira (WRP)

Department of Dermatology, Clinics Hospital of the Medical School of the University of São Paulo, São Paulo, Brazil, walmar.roncalli@hc.fm.usp.br.

Cyro Festa-Neto (C)

Department of Dermatology, Clinics Hospital of the Medical School of the University of São Paulo, São Paulo, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH